Autor: |
Xiaoqing Zhang, Matias A. Bustos, Rebecca Gross, Romela Irene Ramos, Teh‐Ling Takeshima, Gordon B. Mills, Qiang Yu, Dave S. B. Hoon |
Jazyk: |
angličtina |
Rok vydání: |
2021 |
Předmět: |
|
Zdroj: |
Clinical and Translational Medicine, Vol 11, Iss 10, Pp n/a-n/a (2021) |
Druh dokumentu: |
article |
ISSN: |
2001-1326 |
DOI: |
10.1002/ctm2.608 |
Popis: |
Abstract Background 1q21.3 amplification, which is frequently observed in metastatic melanoma, is associated with cancer progression. Interleukin enhancer‐binding factor 2 (ILF2) is located in the 1q21.3 amplified region, but its functional role or contribution to tumour aggressiveness in cutaneous melanoma is unknown. Methods In silico analyses were performed using the TCGA SKCM dataset with clinical annotations and three melanoma microarray cohorts from the GEO datasets. RNA in situ hybridisation and immunohistochemistry were utilised to validate the gene expression in melanoma tissues. Four stable melanoma cell lines were established for in vitro ILF2 functional characterisation. Results Our results showed that the ILF2 copy number variation (CNV) is positively correlated with ILF2 mRNA expression (r = 0.68, p |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|